ArticleNature communications2026

Targeting FGFR signaling overcomes therapeutic resistance and immune evasion in oncogenic PIK3CA-driven serous-like endometrial cancer.

Xin Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.